Sleep Disorders Trial, Recruiting NCT07662733 Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07662733
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years who are scheduled for a planned (non-emergency) keyhole chest surgery called VATS to remove lung cancer.
  • People rated as generally healthy or with only mild health conditions, based on a standard anaesthesia health scoring system (ASA classification I or II).
  • People with a body weight in a moderate range, specifically a Body Mass Index (BMI) between 18.5 and 28 kg/m².
  • People whose lung cancer has been assessed as an early-to-intermediate stage, based on the internationally recognised TNM staging system (8th edition), meaning the cancer has not spread to distant parts of the body (confirm with trial site for exact stage details).
  • People who are mentally capable of understanding and using a simple 0–10 pain rating scale.
  • People who are willing and able to sign a written consent form before the study begins.

Who may not be able to join:

  • People who are in a serious medical condition before surgery, or who are unable to cooperate with the study requirements.
  • People with a history of sleep apnoea or moderate to severe snoring.
  • People who score 7 or above on the Pittsburgh Sleep Quality Index, or 6 or above on the Athens Insomnia Scale — these are standard questionnaires used to measure sleep quality and insomnia.
  • People who have an implanted heart pacemaker, an abnormally slow resting heart rate (50 beats per minute or below), a condition affecting the heart's natural pacemaker (sinoatrial node disease), or certain types of heart rhythm problems (second- or third-degree atrioventricular block).
  • People who regularly take anti-seizure medications, antidepressants, or other medications that affect mood or mental function.
  • People with a known allergy or sensitivity to the needles, devices, or medications used in this study.
  • People with serious heart, liver, or kidney problems.
  • People who have taken part in another clinical trial within the past 3 months.
  • People who have significant difficulties with hearing or language communication.
  • People who are pregnant or breastfeeding.
  • People who have a fever (body temperature of 38.5°C or above) or signs of an active infection before surgery.
  • People for whom a repeat surgery is planned, or where serious complications or illness after surgery are anticipated in a way that would prevent follow-up (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Registry
ClinicalTrials.gov
Start date
13 June 2025
Est. completion
28 February 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of Postoperative Sleep Disturbance as Assessed by the Athens Insomnia Scale (AIS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov